In my latest blog post at bkoffman.blogspot.com, Dr. Byrd discusses a promising drug that could help some of the toughest CLL patients that will probably never become commercially available. We talk about why this is happening and what it means for those of us with CLL.
ASH 2013: Dr. Byrd Discusses Dinaciclib and th... - CLL Support
ASH 2013: Dr. Byrd Discusses Dinaciclib and the Need for More New Drugs to Treat CLL
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
ASH 2014. Dr. Sharman discusses the biology of our CLL cells
Friends,
This week on the CLL Society website http://cllsociety.org, we share the first part of an...
ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)
Friends
In another interview from ASH 2013 that I just posted on my blog...
iwCLL 2013: Dr. Sharman discusses why we feel so lousy, and much more.
Hi friends
In Part 4 of my conversation with Dr. Sharman at iwCLL 2013, we start by discussing the...
Cll Drugs and the Immune System
Which of the newer non-kemo drugs have the least compromising effect on our immune system. I...
ASH 2013: Dr. John Pagel Speculates on the Future of CLL Therapies including the late breaking data on Idelalisib
ASH 2013: Dr. John Pagel Speculates on the Future of CLL (chronic lymphocytic leukemia) Therapies...
Related Posts
ASH 2012 Interview: Dr Jeff Sharman "Why New CLL Treatments Supersede FCR"
New to the group and New to CLL- Dr Peter Hillmen of Leeds, UK discusses the place for Idelalisib in CLL treatment (Patient Power Video)
- Your opportunity to suggest questions for Patient Power ASH 2013 Interviews
quinine to treat cramps and cll patients.
